LUCAR-G79D

· Nanjing Legend Biotech Co.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LUCAR-G79D, covering 2026-02-02 to 2026-02-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LUCAR-G79D in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus (r/r SLE) and Idiopathic Inflammatory Myopathies (r/r IIM) [Phase 1]

See pricing